QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q: What does CUSIP 74754R103 represent in this 13F holders report?

CUSIP 74754R103 is the security identifier for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2022?

28 institutional investors reported QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 74754R103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,138,804
Total 13F shares: 2,808,708
Share change: +113,603
Total reported value: $1,851,111
Price per share: $0.66
Number of holders: 28
Value change: -$24,255
Number of buys: 10
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 74754R103:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q1 2022

As of 31 Mar 2022, QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,808,708 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, FRANKLIN RESOURCES INC, and HighMark Wealth Management LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.